Onderneming Tempest Therapeutics, Inc.
Aandelen
TPST
US87978U1088
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,1 USD | -2,21% | -13,65% | -29,55% |
Vakgebied
Aantal werknemers: 17
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Brady
CEO | Chief Executive Officer | 54 | 01-09-19 |
Nicholas Maestas
DFI | Director of Finance/CFO | 44 | 12-07-21 |
Darrin Bomba
CTO | Chief Tech/Sci/R&D Officer | - | 01-12-21 |
Sam Whiting
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-11-20 |
Comptroller/Controller/Auditor | 36 | 01-06-22 | |
Sharon Sakai
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 56 | 01-07-21 | |
Geoffrey Nichol
BRD | Director/Board Member | 69 | 01-12-19 |
Mike Raab Raab
CHM | Chairman | 59 | 01-01-21 |
Ronit Simantov
BRD | Director/Board Member | 59 | 06-08-21 |
Stephen Brady
CEO | Chief Executive Officer | 54 | 01-09-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 22 192 026 | 21 491 072 ( 96,84 %) | 0 | 96,84 % |
Bedrijfsgegevens
Tempest Therapeutics, Inc.
2000 Sierra Point Parkway Suite 400
94005, Brisbane
+
http://www.tempesttx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-29,55% | 70,35 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |
- Beurs
- Aandelen
- Koers TPST
- Onderneming Tempest Therapeutics, Inc.